GeneDx Holdings (WGS) Operating Income (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Operating Income of -$57.5 million for Q1 2026, down 1162.82% year-over-year from $5.4 million in Q1 2025, and down 303.73% quarter-over-quarter from -$14.2 million in Q4 2025.
GeneDx Holdings (WGS) Operating Income (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Operating Income for 7 consecutive years, with -$57.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income fell 1162.82% year-over-year to -$57.5 million; the TTM figure through Mar 2026 stood at -$66.0 million (down 367.93% YoY), while the FY2025 annual figure was -$13.1 million, up 43.67% from the prior year.
- Operating Income eased to -$57.5 million in Q1 2026 per WGS's latest filing, from -$14.2 million in the prior quarter.
- Across five years, Operating Income topped out at $9.0 million in Q2 2025 and bottomed at -$324.9 million in Q4 2022.
- Historically, Operating Income has averaged -$55.4 million across 5 years, with a median of -$25.6 million in 2023.
- Annual changes were most pronounced in 2025 — Operating Income surged 184.7% — and 2026, when it plunged 1162.82%.
- GeneDx Holdings' Operating Income stood at -$324.9 million in 2022, then jumped by 92.11% to -$25.6 million in 2023, then surged by 134.34% to $8.8 million in 2024, then plunged by 261.65% to -$14.2 million in 2025, then tumbled by 303.73% to -$57.5 million in 2026.
- Business Quant data shows WGS's Operating Income at -$57.5 million in Q1 2026, -$14.2 million in Q4 2025, and -$3.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 2.09 Bn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | 1.13 Bn |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | 425.57 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 399.00 Mn |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 506.00 Mn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | -93.52 Mn |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 245.00 Mn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | 328.45 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 459.00 Mn |
| 10 | GeneDx Holdings | 2.07 Bn | 1.94 Bn | 78.24 Mn | -17.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.46 Mn |
| Mar 31, 2026 | -57.47 Mn |
| Dec 31, 2025 | -14.24 Mn |
| Sep 30, 2025 | -3.25 Mn |
| Jun 30, 2025 | 8.96 Mn |
| Mar 31, 2025 | -4.55 Mn |
| Dec 31, 2024 | 8.81 Mn |
| Sep 30, 2024 | -7.78 Mn |
| Jun 30, 2024 | -10.58 Mn |
| Mar 31, 2024 | -13.66 Mn |
| Dec 31, 2023 | -25.64 Mn |
| Sep 30, 2023 | -42.97 Mn |
| Jun 30, 2023 | -51.62 Mn |
| Mar 31, 2023 | -60.36 Mn |
| Dec 31, 2022 | -324.88 Mn |
| Sep 30, 2022 | -90.82 Mn |
| Jun 30, 2022 | -162.65 Mn |
| Mar 31, 2022 | -89.31 Mn |
| Dec 31, 2021 | -115.78 Mn |
| Sep 30, 2021 | -88.26 Mn |